TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Bohus BioTech AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
4,885
|
5,158
|
2,272 |
| Financial expenses |
307
|
5
|
132 |
| Earnings before taxes |
-4,211
|
4,311
|
-8,672 |
| EBITDA |
-3,812
|
4,422
|
-6,024 |
| Total assets |
10,404
|
5,675
|
4,981 |
| Current assets |
7,803
|
4,069
|
4,136 |
| Current liabilities |
1,421
|
1,759
|
5,036 |
| Equity capital |
2,992
|
3,852
|
-5,154 |
| - share capital |
87
|
90
|
90 |
| Employees (average) |
30
|
29
|
39 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
28.8%
|
67.9%
|
-103.5% |
| Turnover per employee |
163
|
178
|
58 |
| Profit as a percentage of turnover |
-86.2%
|
83.6%
|
-381.7% |
| Return on assets (ROA) |
-37.5%
|
76.1%
|
-171.5% |
| Current ratio |
549.1%
|
231.3%
|
82.1% |
| Return on equity (ROE) |
-140.7%
|
111.9%
|
168.3% |
| Change turnover |
-98
|
2,879
|
-5,659 |
| Change turnover % |
-2%
|
126%
|
-71% |
| Chg. No. of employees |
1
|
-10
|
-10 |
| Chg. No. of employees % |
3%
|
-26%
|
-20% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.